Skye Bioscience, Inc. Other Sundry Liabilities, Current
Skye Bioscience, Inc. (SKYE) had Other Sundry Liabilities, Current of $9.92 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:OtherSundryLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Other Sundry Liabilities, Current $9.92K.
- 2026-03-31: Other Sundry Liabilities, Current $9.92K.
- 2025-12-31: Other Sundry Liabilities, Current $9.92K.
- 2025-09-30: Other Sundry Liabilities, Current $63.59K.
| Period end | Other Sundry Liabilities, Current | Other Sundry Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $9.92K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $9.92K 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $9.92K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $63.59K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $135.03K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $51.12K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $105.05K 10-Q · filed 2025-11-10 | |
| 2024-09-30 | $64.75K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $11.13K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $84.66K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $22.19K 10-Q · filed 2024-11-07 | |
| 2023-09-30 | $106.99K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $306.80K 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $386.60K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $410.35K 10-Q · filed 2023-11-14 | $410.35K 10-K · filed 2023-03-31 |
| 2022-09-30 | $526.82K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $511.26K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $378.11K 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $56.37K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $497.39K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $554.13K 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $318.86K 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $5.46K 10-K · filed 2022-03-28 | $197.56K 10-Q · filed 2021-05-07 |
| 2020-09-30 | $263.83K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $426.88K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $405.34K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $420.41K 10-Q · filed 2020-11-06 | |
| 2019-09-30 | $318.93K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $366.95K 10-Q · filed 2019-08-09 | |
| 2018-12-31 | $184.46K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |